Eledon Pharmaceuticals
ELDN
ELDN
31 hedge funds and large institutions have $17.3M invested in Eledon Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
Holders
31
Holding in Top 10
–
Calls
$48K
Puts
–
Top Buyers
| 1 | +$63.7K | |
| 2 | +$57.2K | |
| 3 | +$32.4K | |
| 4 |
EP
Eversept Partners
New York
|
+$27.6K |
| 5 |
BlackRock
New York
|
+$3.42K |
Top Sellers
| 1 | -$448K | |
| 2 | -$260K | |
| 3 | -$170K | |
| 4 |
B
Bailard
Foster City,
California
|
-$67K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$40.1K |